article thumbnail

How Digital Health improves patient experiences in Alzheimer’s care

Digital Health Global

The global healthcare problem faced by Alzheimer’s disease (AD), which is characterized by progressive cognitive decline, memory loss, and behavioral abnormalities, has never been more pressing. With an aging population, the prevalence of Alzheimer’s disease is increasing, making it a key point for healthcare innovation.

article thumbnail

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Healthcare IT Today

Flywheel’s products transform healthcare innovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development,” said Flywheel CEO, Jim Olson. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A with Rami Rajab and Inna Nadelwais, Mecomed

Healthcare Innovation Consortium

The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded. We hope that medical devices will contribute to solving this problem, by looking at the issue with innovative solutions, not just in terms of new antimicrobials but by prevention of the infection and awareness.

BioTech 60
article thumbnail

Moving the Needle with Real World Data: How Oncology is Leading the Way

GNS Healthcare

The thought of gathering massive amounts of data, from claims to EHR to molecular and making it easily accessible for drug development research once seemed impossible, as did getting at previously 'undruggable' pathways that defied the effects of even the most innovative drugs.

article thumbnail

Moving the Needle with Real World Data: How Oncology is Leading the Way

GNS Healthcare

The thought of gathering massive amounts of data, from claims to EHR to molecular and making it easily accessible for drug development research once seemed impossible, as did getting at previously 'undruggable' pathways that defied the effects of even the most innovative drugs.

article thumbnail

Sovereign Health Fund: time to unlock the potential £5Bn ARR asset based on unique NHS datasets?

Lloyd Price

Proponents of the sovereign health fund argue that it would be a more efficient and effective way to fund healthcare than the current system. They say that the fund would be able to identify and invest in the most promising healthcare innovations, and that it would be able to do so at a lower cost than the NHS.